Subcutaneously administered repronex® in oligoovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment
- 31 July 2001
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 76 (1) , 58-66
- https://doi.org/10.1016/s0015-0282(01)01856-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Subcutaneously administered repronex in female patients undergoing in vitro fertilization is as effective and well tolerated as intramuscular menotropin treatmentFertility and Sterility, 2000
- Local Side Effects of Subcutaneous and Intramuscular Urinary Gonadotropins for Ovarian Stimulation in In Vitro Fertilization: A Prospective, Randomized StudyFertility and Sterility, 1998
- Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropinsFertility and Sterility, 1997
- A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon)Fertility and Sterility, 1997
- Endocrinology: Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilizationHuman Reproduction, 1996
- Endocrinology: Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophinHuman Reproduction, 1996
- The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic womenHuman Reproduction, 1996
- Retrospective analysis of subcutaneous administration of urinary gonadotrophins inin vitrofertilisationJournal of Obstetrics and Gynaecology, 1996
- Comparison of Efficacy of High-Dose Pure Follicle-Stimulating Hormone versus Human Menopausal Gonadotropins for in vitro FertilizationGynecologic and Obstetric Investigation, 1995
- Human gonadotrophin preparations May cause allergic reactionBMJ, 1994